Header cover image

Norwegian (OSEAX) Biotech Industry Analysis

UpdatedJun 21, 2025
DataAggregated Company Financials
Companies11
  • 7D-2.7%
  • 3M-4.2%
  • 1Y-54.0%
  • YTDn/a

Over the last 7 days, the Biotech industry has dropped 4.7%, driven by Hofseth BioCare declining 8.3%. The industry has fallen 57% in the last year. As for the next few years, earnings are expected to grow by 33% per annum.

Industry Valuation and Performance

Has the Norwegian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 21 Jun 2025NOK 4.8bNOK 885.3m-NOK 745,251,650.83197.3x-6.5x5.5x
Mon, 19 May 2025NOK 5.2bNOK 896.8m-NOK 892,897,037.39195x-5.8x5.8x
Wed, 16 Apr 2025NOK 4.8bNOK 521.8m-NOK 1,027,238,411.99114x-4.7x9.2x
Fri, 14 Mar 2025NOK 4.7bNOK 522.1m-NOK 1,103,516,607.51114.7x-4.3x9x
Sun, 09 Feb 2025NOK 5.1bNOK 457.1m-NOK 1,121,416,201.72154.5x-4.6x11.2x
Tue, 07 Jan 2025NOK 4.7bNOK 457.3m-NOK 1,070,730,820.52156.7x-4.3x10.2x
Thu, 05 Dec 2024NOK 4.2bNOK 456.2m-NOK 1,061,750,226.30147.7x-4x9.3x
Sat, 02 Nov 2024NOK 4.6bNOK 472.8m-NOK 1,074,585,104.0560.3x-4.3x9.7x
Mon, 30 Sep 2024NOK 5.0bNOK 469.2m-NOK 1,047,120,820.3563x-4.8x10.7x
Wed, 28 Aug 2024NOK 6.2bNOK 467.8m-NOK 1,043,998,898.1070.7x-6x13.3x
Fri, 26 Jul 2024NOK 8.8bNOK 518.1m-NOK 1,057,386,592.6969.5x-8.3x17x
Sun, 23 Jun 2024NOK 8.9bNOK 641.0m-NOK 938,795,223.8336.6x-9.5x13.9x
Tue, 21 May 2024NOK 8.8bNOK 638.8m-NOK 978,127,299.4431.8x-9x13.7x
Thu, 18 Apr 2024NOK 8.3bNOK 660.5m-NOK 949,322,089.4637.1x-8.8x12.6x
Sat, 16 Mar 2024NOK 9.0bNOK 655.4m-NOK 935,914,720.5440.8x-9.6x13.7x
Mon, 12 Feb 2024NOK 15.2bNOK 672.2m-NOK 1,064,025,055.7441.6x-14.3x22.6x
Wed, 10 Jan 2024NOK 17.0bNOK 654.9m-NOK 1,354,587,829.0059.7x-12.5x25.9x
Fri, 08 Dec 2023NOK 15.0bNOK 662.6m-NOK 1,376,912,857.0056.7x-10.9x22.7x
Sun, 05 Nov 2023NOK 13.8bNOK 491.0m-NOK 1,549,505,083.0093x-8.9x28.1x
Tue, 03 Oct 2023NOK 15.3bNOK 626.0m-NOK 1,460,595,304.0055.4x-10.5x24.4x
Thu, 31 Aug 2023NOK 15.7bNOK 625.9m-NOK 1,430,493,766.0058.5x-11x25.1x
Sat, 29 Jul 2023NOK 16.3bNOK 555.1m-NOK 1,452,076,250.0058.2x-11.3x29.5x
Mon, 26 Jun 2023NOK 15.4bNOK 562.7m-NOK 1,483,024,567.0057.5x-10.4x27.4x
Wed, 24 May 2023NOK 17.3bNOK 562.8m-NOK 1,497,067,181.0064x-11.6x30.8x
Fri, 21 Apr 2023NOK 17.4bNOK 540.4m-NOK 1,450,451,254.0030.1x-12x32.2x
Sun, 19 Mar 2023NOK 15.0bNOK 538.6m-NOK 1,566,658,506.0029.5x-9.6x27.8x
Tue, 14 Feb 2023NOK 18.4bNOK 811.4m-NOK 1,413,475,376.0033.3x-13x22.7x
Thu, 12 Jan 2023NOK 18.1bNOK 812.7m-NOK 1,396,218,028.0025.5x-13x22.3x
Sat, 10 Dec 2022NOK 20.0bNOK 811.4m-NOK 1,395,546,113.0039.6x-14.3x24.6x
Mon, 07 Nov 2022NOK 17.4bNOK 805.0m-NOK 1,362,634,267.0036.1x-12.8x21.7x
Wed, 05 Oct 2022NOK 17.6bNOK 809.1m-NOK 1,363,217,532.0037.6x-12.9x21.7x
Fri, 02 Sep 2022NOK 20.5bNOK 795.0m-NOK 1,370,975,728.0036.8x-15x25.8x
Sun, 31 Jul 2022NOK 20.7bNOK 762.8m-NOK 1,379,134,362.0044.9x-15x27.2x
Tue, 28 Jun 2022NOK 19.9bNOK 765.8m-NOK 1,379,977,396.0043.2x-14.4x26x
Price to Earnings Ratio

-14.4x


Total Market Cap: NOK 19.9bTotal Earnings: -NOK 1,379,977,396.00Total Revenue: NOK 765.8mTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Biotech Industry Price to Earnings3Y Average -9.7x202320242025
Current Industry PE
  • Investors are pessimistic on the Norwegian Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 19.4x is higher than the industry's current PS ratio of 5.2x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have improved over the last three years.
  • Revenues for these companies have grown 4.9% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Comparison

How does Norwegian Biotech compare with similar industries?

NO Market1.06%
Healthcare0.92%
Biotech-2.72%
Biotech-2.72%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TRMED Thor MedicalNOK 2.56-3.0%
NOK 63.4m
156.3%PB2.6x
LYTIX Lytix BiopharmaNOK 9.783.2%
+NOK 20.5m
8.7%PS1098x
AZT ArcticZymes TechnologiesNOK 16.800.3%
+NOK 2.6m
-31.6%PE391.4x
CRNA Circio HoldingNOK 0.642.7%
+NOK 1.7m
-75.4%PE1.1x
BGBIO BerGenBioNOK 1.413.1%
+NOK 1.6m
-86.6%PS65.1x

Latest News